- Início
- Euronext Bruxelas
- Company regulated news
- Archive
- Company press releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
21 Jul 2022 07:00 CEST |
ARGENX SE | argenx to Report Half Year 2022 Financial Results and Second Quarter Business Update on July 28, 2022 | 20103010 Biotechnology | Other subject |
20 Jul 2022 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : Acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
20 Jul 2022 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : Inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
20 Jul 2022 17:55 CEST |
DMS IMAGING | Chiffre d'affaires en croissance de +4% au 2ème trimestre 2022 | 20103010 Biotechnology | Legal |
20 Jul 2022 08:30 CEST |
UMICORE | Umicore - Déclaration de transparence par Bank of America | 55201020 Specialty Chemicals | New |
20 Jul 2022 08:30 CEST |
UMICORE | Umicore - Transparantieverklaring van Bank of America | 55201020 Specialty Chemicals | New |
20 Jul 2022 08:30 CEST |
UMICORE | Umicore - Transparency notification by Bank of America | 55201020 Specialty Chemicals | New |
20 Jul 2022 08:00 CEST |
EURONAV | Euronav kondigt Q2 2022 resultaten aan op donderdag 4 augustus 2022 | 50206030 Marine Transportation | Other subject |
20 Jul 2022 08:00 CEST |
EURONAV | Euronav to announce Q2 2022 results on Thursday 4 August 2022 | 50206030 Marine Transportation | Other subject |
20 Jul 2022 07:00 CEST |
HYLORIS | Hyloris Reports Positive Phase 1 Data for HY-004, a proprietary Tranexamic Acid Oral Mouth Rinse for bleeding related to dental procedures | 20103010 Biotechnology | Products and services |
20 Jul 2022 07:00 CEST |
HYLORIS | Hyloris présente des données positives pour la phase 1 de HY-004, un Acide Tranexamique Oral - Rinçage Buccal exclusif indiqué dans les saignements liés aux interventions dentaires | 20103010 Biotechnology | Products and services |
19 Jul 2022 22:30 CEST |
NYXOAH SA | Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022 | 20102010 Medical Equipment | Other subject |
19 Jul 2022 22:30 CEST |
NYXOAH SA | Nyxoah Publiera ses Résultats Financiers pour le Deuxième Trimestre et pour le Premier Semestre le 8 août 2022 | 20102010 Medical Equipment | Other subject |
19 Jul 2022 18:00 CEST |
WERELDHAVE BELGIUM | Rapport financier semestriel 30 juin 2022 | 35102045 Retail REITs | New |
19 Jul 2022 18:00 CEST |
WERELDHAVE BELGIUM | Halfjaarlijks financieel verslag 30 juni 2022 | 35102045 Retail REITs | New |
19 Jul 2022 18:00 CEST |
WERELDHAVE BELGIUM | Half-yearly financial report 30 June 2022 | 35102045 Retail REITs | New |
18 Jul 2022 22:30 CEST |
NYXOAH SA | Nyxoah Announces CE Mark Approval for Genio® 2.1 | 20102010 Medical Equipment | Other subject |
18 Jul 2022 22:30 CEST |
NYXOAH SA | Nyxoah annonce l'approbation du marquage CE pour Genio® 2.1 | 20102010 Medical Equipment | Other subject |
18 Jul 2022 18:07 CEST |
GBL | GBL - Transacties op GBL-aandelen 18-07-2022 | 30202000 Diversified Financial Services | Other financial transaction |
18 Jul 2022 18:06 CEST |
GBL | GBL - Transactions sur actions propres 18-07-2022 | 30202000 Diversified Financial Services | Other financial transaction |
18 Jul 2022 18:04 CEST |
GBL | GBL - Transactions on GBL shares 18-07-2022 | 30202000 Diversified Financial Services | Other financial transaction |
18 Jul 2022 17:40 CEST |
KBC ANCORA ord | Update on share repurchase program KBC Ancora until 15 July 2022 | 30101010 Banks | Other subject |
18 Jul 2022 17:40 CEST |
AGEAS | Ageas rapporteert over de inkoop van eigen aandelen | 30301010 Life Insurance | Other financial transaction |
18 Jul 2022 17:40 CEST |
AGEAS | Ageas reports on the progress of share buy-back programme | 30301010 Life Insurance | Other financial transaction |
18 Jul 2022 17:40 CEST |
KBC ANCORA ord | Mise à jour du programme de rachat d’actions propres KBC Ancora jusqu’au 15 juillet 2022 | 30101010 Banks | Other subject |
18 Jul 2022 17:40 CEST |
AGEAS | Rapport d’Ageas sur le programme de rachat d’actions | 30301010 Life Insurance | Other financial transaction |
18 Jul 2022 17:40 CEST |
KBC ANCORA ord | Update inkoopprogramma KBC Ancora tot 15 juli 2022 | 30101010 Banks | Other subject |
18 Jul 2022 09:58 CEST |
RECTICEL | CMA opens phase 2 investigation | 50203015 Plastics | Other subject |
18 Jul 2022 09:58 CEST |
RECTICEL | CMA opent fase 2 onderzoek | 50203015 Plastics | Other subject |
18 Jul 2022 08:45 CEST |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
18 Jul 2022 08:43 CEST |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
18 Jul 2022 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Buy back of own shares – week from 11/07/2022 to 15/07/2022 | 30202010 Asset Managers and Custodians | Other subject |
18 Jul 2022 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage : Rachat d’actions propres – semaine du 11/07/2022 au 15/07/2022 | 30202010 Asset Managers and Custodians | Other subject |
18 Jul 2022 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 11/07/2022 tot 15/07/2022 | 30202010 Asset Managers and Custodians | Other subject |
18 Jul 2022 07:30 CEST |
SOLVAY | Solvay annonce des résultats records pour le deuxième trimestre 2022, bien au-delà des attentes | 55201000 Chemicals: Diversified | Corporate life |
18 Jul 2022 07:30 CEST |
SOLVAY | Solvay verwacht recordresultaten voor het tweede kwartaal van 2022, ruim boven verwachting | 55201000 Chemicals: Diversified | Corporate life |
18 Jul 2022 07:30 CEST |
SOLVAY | Solvay to deliver record Q2 2022 results well ahead of expectations | 55201000 Chemicals: Diversified | Corporate life |
18 Jul 2022 07:25 CEST |
JENSEN-GROUP | Update: Inkoop eigen aandelen | 50204000 Machinery: Industrial | Other subject |
18 Jul 2022 07:22 CEST |
JENSEN-GROUP | Update: share buy back | 50204000 Machinery: Industrial | Other subject |
18 Jul 2022 04:00 CEST |
AZELIS GROUP NV | Azelis expands Personal Care footprint in Asia Pacific with the acquisition of Chemical Solutions Sdn Bhd in Malaysia | 55201000 Chemicals: Diversified | Mergers, Acquiqitions, Transferts |
15 Jul 2022 09:43 CEST |
CARE PROPERTY INVEST | Care Property Invest completes the Spanish residential care centre 'Emera Carabanchel' | 35102040 Residential REITs | Commercial operations |
15 Jul 2022 09:42 CEST |
CARE PROPERTY INVEST | Care Property Invest a achevé la construction du centre de services de soins et de logement espagnol « Emera Carabanchel » | 35102040 Residential REITs | Commercial operations |
15 Jul 2022 09:42 CEST |
CARE PROPERTY INVEST | Care Property Invest levert Spaans woonzorgcentrum “Emera Carabanchel” op | 35102040 Residential REITs | Commercial operations |
15 Jul 2022 08:00 CEST |
KBC | KBC Group: Publication of transparency notification(s) received by KBC Group NV | 30101010 Banks | Other subject |
15 Jul 2022 08:00 CEST |
BEKAERT | Bekaert - Mise à jour relative au Programme de Rachat d’Actions et au Contrat de Liquidité | 55102010 Iron and Steel | Legal |
15 Jul 2022 08:00 CEST |
KBC | KBC Groep: Openbaarmaking van transparantiekennis-geving(en) ontvangen door KBC Groep NV | 30101010 Banks | Other subject |
15 Jul 2022 08:00 CEST |
BEKAERT | Bekaert - Update over het Inkoop van Eigen Aandelen Programma en de Liquiditeitsovereenkomst | 55102010 Iron and Steel | Legal |
15 Jul 2022 08:00 CEST |
BEKAERT | Bekaert - Update on the Share Buyback Program and the Liquidity Agreement | 55102010 Iron and Steel | Legal |
15 Jul 2022 07:00 CEST |
BONE THERAPEUTICS | Bone Therapeutics optimizes statistical analysis and introduces interim analysis in the ongoing ALLOB Phase IIb study for high-risk tibial fractures | 20103010 Biotechnology | Other subject |
15 Jul 2022 07:00 CEST |
BONE THERAPEUTICS | Bone Therapeutics optimise l'analyse statistique et introduit une analyse intermédiaire dans l'étude de phase IIb ALLOB en cours dans les fractures du tibia à haut risque | 20103010 Biotechnology | Other subject |